oral non-peptide GLP-1R agonist Ph. III for obesity + type 2 diabetes from LLC-PK1 cell HTS + opt N. Engl. J. Med., June 23, 2023 Chugai, Shizuoka, JP; Eli Lilly, Indianapolis, IN